Skip to main content

Table 3 Family medical history

From: Demography, baseline disease characteristics, and treatment history of psoriasis patients with self-reported psoriatic arthritis enrolled in the PSOLAR registry

  Psoriasis patients self-reporting PsA, established by a HCPa (N = 1719) Psoriasis patients self-reporting PsAb (N = 4315) Patients with psoriasis onlyc (N = 7775) All PSOLAR patientsd (N = 12,090)
Patients with family history data, N 1676 4205 7520 11,725
Psoriatic arthritis 275 (16.4)* 736 (17.5)* 471 (6.3) 1207 (10.3)
Cardiovascular disease 894 (53.3)* 2105 (50.1)* 3124 (41.5) 5229 (44.6)
Psoriasis 837 (49.9)* 2041 (48.5)* 3286 (43.7) 5327 (45.4)
Inflammatory bowel disease 135 (8.1) 345 (8.2)* 423 (5.6) 768 (6.6)
 Indeterminate colitis 48 (2.9) 94 (2.2) 108 (1.4) 202 (1.7)
 Crohn’s disease 40 (2.4) 75 (1.8) 125 (1.7) 200 (1.7)
 Ulcerative colitis 41 (2.4) 62 (1.5) 94 (1.3) 156 (1.3)
 Sprue/Celiac disease 7 (0.4) 12 (0.3) 30 (0.4) 42 (0.4)
Diabetes 683 (40.8)** 1755 (41.7)* 2768 (36.8) 4523 (38.6)
Other cancer 640 (38.2)* 1508 (35.9)* 2393 (31.8) 3901 (33.3)
Asthma 371 (22.1)* 918 (21.8)* 1338 (17.8) 2256 (19.2)
Thyroid disease 307 (18.3)* 771 (18.3)* 1114 (14.8) 1885 (16.1)
Non-melanoma skin cancer 203 (12.1)** 518 (12.3)* 749 (10.0) 1267 (10.8)
Rashes 152 (9.1) 304 (7.2)ns 464 (6.2) 768 (6.6)
Melanoma skin cancer 102 (6.1)** 268 (6.4)* 367 (4.9) 635 (5.4)
Multiple sclerosis 30 (1.8) 99 (2.4)* 112 (1.5) 211 (1.8)
Vitiligo 47 (2.8)** 103 (2.4)ns 128 (1.7) 231 (2.0)
None 127 (7.6) 369 (8.8)* 992 (13.2) 1361 (11.6)
  1. Values are n (%)
  2. HCP healthcare provider, PsA psoriatic arthritis, ns not significant
  3. *p < 0.001 vs. patients with psoriasis only
  4. ** p < 0.05 vs. patients with psoriasis only
  5. ns indicates non-significant for psoriasis patients self-reporting PsA vs. patients with psoriasis only
  6. P-values for categorical variables were obtained from Pearson chi-square test with patients with psoriasis only as a reference
  7. aA subset of PSOLAR psoriasis patients self-reporting PsA, established by a HCP
  8. bPSOLAR psoriasis patients with self-reported PsA
  9. cPSOLAR psoriasis patients not self-reporting PsA
  10. dIncludes all PSOLAR patients with psoriasis who may or may not have PsA